ScripsAmerica's Specialty Pharmacy Records Monthly Revenue of $1.6 Million in May
June 02 2014 - 8:30AM
Marketwired
ScripsAmerica's Specialty Pharmacy Records Monthly Revenue of $1.6
Million in May
TYSONS CORNER, VA--(Marketwired - Jun 2, 2014) - ScripsAmerica,
Inc. (OTCBB: SCRC) today announced that its managed specialty
pharmacy reported $1.6 million in prescription sales during the
month of May.
Main Avenue Pharmacy's $1.6 million in monthly revenue for May
represents a 67% increase over April's revenue and 224% increase
over March's revenue. ScripsAmerica fully manages the operations of
the specialty pharmacy, which focuses on compounding topical
creams. May's sales have significantly increased Main Avenue
Pharmacy's annual run rate to $19.2 million.
"ScripsAmerica is pleased to report that Main Avenue Pharmacy's
revenue is continuing its aggressive monthly revenue growth and has
already generated $3.2 million for the Company since we began
managing its operations just over three months ago. This new area
of business will increase our shareholder value as the pharmacy's
compounded topical pain creams continue to see growing demand and
expands its sales into new states," commented ScripsAmerica's CEO,
Bob Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and
nutraceutical drugs, delivering pharmaceutical products to a wide
range of end users across the health care industry. End users
include retail pharmacies, hospitals, long-term care facilities and
government and home care agencies. For more information, visit
www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are
based on certain assumptions and reflects management's current
expectations. These forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
or events to differ materially from current expectations. Some of
these factors include: general global economic conditions; general
industry and market conditions, sector changes and growth rates;
uncertainty as to whether our strategies and business plans will
yield the expected benefits; increasing competition; availability
and cost of capital; the ability to identify and develop and
achieve commercial success; the level of expenditures necessary to
maintain and improve the quality of services; changes in
the economy; changes in laws and regulations, including codes and
standards, intellectual property rights, and tax matters; or other
matters not anticipated; our ability to secure and maintain
strategic relationships and distribution agreements. The Company
disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise.
Contact: Seal Point Consulting 888-959-7095 Email Contact
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
ScripsAmerica (CE) (USOTC:SCRCQ)
Historical Stock Chart
From Apr 2023 to Apr 2024